AbbVie showcases its leadership in Rheumatology research with new data across multiple inflammatory joint diseases
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU
Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
A primary investment of Rs 194.4 crore has been made
Subscribe To Our Newsletter & Stay Updated